Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Baldini

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Critical Reviews in Oncology/Hematology|February 24, 2024
Patients' selection and trial matching in early-phase oncology clinical trialsP Corbaux, A Bayle, S Besle, et al.
Reumatismo|January 20, 2012
[MALDI-TOF and SELDI-TOF analysis: "tandem" techniques to identify potential biomarker in fibromyalgia]C Giacomelli, L Bazzichi, L Giusti, et al.
Clinical and Experimental Rheumatology|November 18, 2009
Ultrasound imaging for the rheumatologist. XXIII. Sonographic evaluation of hand joint involvement in primary Sjögren's syndromeL Riente, C A Scirè, A Delle Sedie, et al.
Lupus|October 10, 2014
A retrospective, multicenter study evaluating the prognostic value of minor salivary gland histology in a large cohort of patients with primary Sjögren's syndromeF Carubbi, A Alunno, P Cipriani, et al.
Clinical Rheumatology|March 5, 2013
Analysis of the prevalence of cataracts and glaucoma in systemic lupus erythematosus and evaluation of the rheumatologists' practice for the monitoring of glucocorticoid eye toxicityL Carli, C Tani, F Querci, et al.
Journal of Internal Medicine|January 14, 2015
Cardiovascular disease risk burden in primary Sjögren's syndrome: results of a population-based multicentre cohort studyE Bartoloni, C Baldini, G Schillaci, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Real-world safety and effectiveness of neoadjuvant chemotherapy combination with pembrolizumab in triple-negative breast cancerL Rached, F Peyre-Pradat, M Spotti, et al.
Autoimmunity Reviews|October 16, 2012
Rhupus syndrome: assessment of its prevalence and its clinical and instrumental characteristics in a prospective cohort of 103 SLE patientsC Tani, D D'Aniello, A Delle Sedie, et al.
ESMO Open|August 14, 2025
Addressing screening failures in early-phase clinical trials in oncology: impact on patient outcomes and strategies for improvementI Korakis, K Ouali, B Hanvic, et al.
Cancer Chemotherapy and Pharmacology|June 24, 2023
Infections occurring following IL6 blockade for the management of cytokine release syndrome in onco-hematology patientsM Valery, K Saleh, R Ecea, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Critical Reviews in Oncology/Hematology|February 24, 2024
Patients' selection and trial matching in early-phase oncology clinical trialsP Corbaux, A Bayle, S Besle, et al.
Reumatismo|January 20, 2012
[MALDI-TOF and SELDI-TOF analysis: "tandem" techniques to identify potential biomarker in fibromyalgia]C Giacomelli, L Bazzichi, L Giusti, et al.
Clinical and Experimental Rheumatology|November 18, 2009
Ultrasound imaging for the rheumatologist. XXIII. Sonographic evaluation of hand joint involvement in primary Sjögren's syndromeL Riente, C A Scirè, A Delle Sedie, et al.
Lupus|October 10, 2014
A retrospective, multicenter study evaluating the prognostic value of minor salivary gland histology in a large cohort of patients with primary Sjögren's syndromeF Carubbi, A Alunno, P Cipriani, et al.
Clinical Rheumatology|March 5, 2013
Analysis of the prevalence of cataracts and glaucoma in systemic lupus erythematosus and evaluation of the rheumatologists' practice for the monitoring of glucocorticoid eye toxicityL Carli, C Tani, F Querci, et al.
Journal of Internal Medicine|January 14, 2015
Cardiovascular disease risk burden in primary Sjögren's syndrome: results of a population-based multicentre cohort studyE Bartoloni, C Baldini, G Schillaci, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Real-world safety and effectiveness of neoadjuvant chemotherapy combination with pembrolizumab in triple-negative breast cancerL Rached, F Peyre-Pradat, M Spotti, et al.
Autoimmunity Reviews|October 16, 2012
Rhupus syndrome: assessment of its prevalence and its clinical and instrumental characteristics in a prospective cohort of 103 SLE patientsC Tani, D D'Aniello, A Delle Sedie, et al.
ESMO Open|August 14, 2025
Addressing screening failures in early-phase clinical trials in oncology: impact on patient outcomes and strategies for improvementI Korakis, K Ouali, B Hanvic, et al.
Cancer Chemotherapy and Pharmacology|June 24, 2023
Infections occurring following IL6 blockade for the management of cytokine release syndrome in onco-hematology patientsM Valery, K Saleh, R Ecea, et al.
Pageof 5